Q1 2019 ASP Payment Limit Report

CMS has released the Q1 2019 drug pricing files for both average sales price (ASP) and not otherwise classified (NOC) drugs. These changes are effective January 1, 2019, and will remain in effect until either a correction or the next scheduled update is made by CMS.

The data used for the Q1 2019 reimbursement files is based on the Q3 2018 sales data submitted to CMS by drug manufacturers. We encourage you to review the revised drug payment limit files, including reimbursement allowables on NOC drugs, on the CMS website.

Access the Oncology Payment Limit Report.

Access the Neurology Payment Limit Report.

Access the Rheumatology/Gastroenterology Payment Limit Report.

Access the Nephrology Payment Limit Report.

Access the Urology Payment Limit Report.

Access the Multi-Specialty Payment Limit Report.